Scripta Therapeutics raises $12M in a seed round to find disease-modifying drugs that alter transcription factor activity, led by Oxford Science Enterprises and Apollo Health Ventures.
Amount Raised
$12 Million
Round Type
Seed
Investors
Description
Techbio startup Scripta Therapeutics has emerged from stealth with a $12 million seed round. The funding aims to revolutionize drug discovery through a unique approach focusing on transcription factors. The round is backed by Oxford Science Enterprises and Apollo Health Ventures, alongside other investors. Scripta's innovative strategy targets conditions like Alzheimer’s disease.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Scripta Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- Initiate raised an undisclosed amount (Private Equity) on December 23, 2025.
- FONAR raised $41M on December 23, 2025.
- Vyriad raised $25M (Series B) on December 23, 2025.
- Kashiv BioSciences raised $72M (Debt Financing) on December 23, 2025.
- FONAR raised $10M on December 23, 2025.
Who to call at Scripta Therapeutics, and when
A new round usually means Scripta Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Scripta Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Scripta Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Scripta Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Scripta Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Scripta Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.